PDLI Net Income Growth
Pdl Biopharma Inc · Net Income Growth
PDLI Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported100.00%period ending
PDLI Quarterly Net Income YoY % (79.07% → 100.00%)
Year-over-year change
High-resolution chart · PNG
PDLI net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 100% | |
| -1,030.8215% | |
| -574.8952% | |
| -437.1706% | |
| -169.5884% | |
| 96.0649% | |
| 316.9788% | |
| -27.1177% | |
| 23.2684% | |
| -285.8006% | |
| -77.876% | |
| 316.0991% | |
| 49.076% | |
| 1,357.0636% | |
| -87.0435% | |
| -110.277% | |
| -79.9781% | |
| -94.7% | |
| -33.86% | |
| 82.6261% | |
| -32.0595% | |
| -14.9813% | |
| 15.9365% | |
| -9.8556% | |
| 81.8319% | |
| -1.7996% | |
| 36.3038% | |
| 23.648% | |
| 15.7488% | |
| 27.5367% | |
| 33.0654% | |
| 26.8759% | |
| 5.791% | |
| 5.0239% | |
| -9.7901% | |
| 259.2069% | |
| 14.2502% | |
| 39.5867% | |
| 71.2808% | |
| -185.6443% | |
| -13.397% | |
| -35.0855% | |
| -30.5684% | |
| -29.7227% | |
| -16.6724% | |
| 127.6229% | |
| 160.5366% | |
| 360.8576% | |
| 1,062.8458% | |
| 113.0604% | |
| -483.3962% | |
| 82.6337% | |
| 13.967% | |
| 316.4153% | |
| 59.5654% | |
| -124.7645% | |
| 82.9149% | |
| -115.1754% | |
| 68.7347% | |
| -173.7073% | |
| -189.5724% | |
| 72.5345% | |
| -564.8835% | |
| 79.9865% | |
| 28.0053% | |
| 70.4572% | |
| -410.1008% | |
| -824.1629% | |
| -136.2032% | |
| -7,440.0716% | |
| 116.3211% | |
| -47.4196% | |
| -349.9437% | |
| -117.8025% | |
| -71.6332% | |
| -10,386.2745% | |
| 65.1355% | |
| -37.4751% | |
| 761.1688% | |
| 99.1356% | |
| -2,647% | |
| 286% | |
| 140.5263% | |
| -13.4615% | |
| -71.4286% | |
| -200% | |
| 52.5% | |
| 67.7019% | |
| 177.7778% | |
| 67.8571% | |
| 2.439% | |
| -794.4444% | |
| 79.0698% |